Revelation Biosciences (REVB) EPS (Basic) (2021 - 2026)
Revelation Biosciences (REVB) posted quarterly EPS (Basic) of -$4.04 for Q4 2025, up 96.65% year-over-year from -$2.06 in Q4 2024, and up 42.82% quarter-over-quarter from -$7.07 in Q3 2025.
Revelation Biosciences (REVB) EPS (Basic) (2021 - 2026) Analysis & Trends
Revelation Biosciences (REVB) has reported EPS (Basic) for 5 consecutive years, with -$4.04 the latest figure, recorded in Q4 2025.
- In Q4 2025, EPS (Basic) rose 96.65% year-over-year to -$4.04; the TTM figure through Dec 2025 stood at -$24.02 (up 97.6% YoY), while the FY2025 annual figure was -$23.95, up 97.72% from the prior year.
- EPS (Basic) grew to -$4.04 in Q4 2025 per REVB's latest filing, from -$7.07 in the prior quarter.
- Across five years, EPS (Basic) topped out at $205.89 in Q3 2021 and bottomed at -$289519.2 in Q1 2021.
- Historically, EPS (Basic) has averaged -$22957.0 across 5 years, with a median of -$663.86 in 2024.
- Annual changes were most pronounced in 2022 — EPS (Basic) slumped 13107.97% — and 2024, when it soared 98.88%.
- Revelation Biosciences' EPS (Basic) stood at $130.22 in 2021, then plunged by 13107.97% to -$16939.3 in 2022, then surged by 36.41% to -$10772.3 in 2023, then soared by 98.88% to -$120.75 in 2024, then surged by 96.65% to -$4.04 in 2025.
- Business Quant data shows REVB's EPS (Basic) at -$4.04 in Q4 2025, -$7.07 in Q3 2025, and -$28.04 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Revelation Biosciences | 4.17 Mn | -7.33 Mn | - | -0.87 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.87 |
| Dec 31, 2025 | -4.04 |
| Sep 30, 2025 | -7.07 |
| Jun 30, 2025 | -28.04 |
| Mar 31, 2025 | -25.88 |
| Dec 31, 2024 | -120.75 |
| Sep 30, 2024 | -160.59 |
| Jun 30, 2024 | -985.07 |
| Mar 31, 2024 | -342.66 |
| Dec 31, 2023 | -10,772.30 |
| Sep 30, 2023 | -2,567.97 |
| Jun 30, 2023 | -1,973.05 |
| Mar 31, 2023 | -4,444.05 |
| Dec 31, 2022 | -16,939.27 |
| Sep 30, 2022 | -11,698.62 |
| Jun 30, 2022 | -25,264.07 |
| Mar 31, 2022 | -94,826.83 |
| Dec 31, 2021 | 130.22 |
| Sep 30, 2021 | 205.89 |
| Jun 30, 2021 | 203.67 |